miR-630 targets IGF1R to regulate response to HER-targeting drugs and overall cancer cell progression in HER2 over-expressing breast cancer
2014 · Molecular Cancer · 77 citations
https://doi.org/10.1186/1476-4598-13-71
M
Martina Gogarty
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
38
Papers
617
Citations
14
h-index
14
i10-index
Martina Gogarty is an academic researcher from Trinity College Dublin. The author has contributed to research in topics: HER2/EGFR in Cancer Research & Advanced Breast Cancer Therapies & Cancer Treatment and Pharmacology. The author has an h-index of 14, co-authored 33 publications.
ORCID: 0000-0002-1364-1582Papers by this author
worksApolipoprotein A-I infiltration in rheumatoid arthritis synovial tissue: a control mechanism of cytokine production?
2004 · Arthritis Research & Therapy · 62 citations
https://doi.org/10.1186/ar1443
Change in CD3 positive T-cell expression in psoriatic arthritis synovium correlates with change in DAS28 and magnetic resonance imaging synovitis scores following initiation of biologic therapy - a single centre, open-label study
2011 · Arthritis Research & Therapy · 46 citations
https://doi.org/10.1186/ar3228
IL-36 cytokines imprint a colitogenic phenotype on CD4+ T helper cells
2022 · Mucosal Immunology · 19 citations
https://doi.org/10.1038/s41385-022-00488-w
Editorial Expression of Concern: miR-630 targets IGF1R to regulate response to HER-targeting drugs and overall cancer cell progression in HER2 over-expressing breast cancer
2024 · Molecular Cancer · 0 citations
https://doi.org/10.1186/s12943-024-02139-z
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat